{
     "PMID": "26340979",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20160823",
     "LR": "20171030",
     "IS": "1573-7365 (Electronic) 0885-7490 (Linking)",
     "VI": "30",
     "IP": "6",
     "DP": "2015 Dec",
     "TI": "Ferulic acid chronic treatment exerts antidepressant-like effect: role of antioxidant defense system.",
     "PG": "1453-63",
     "LID": "10.1007/s11011-015-9725-6 [doi]",
     "AB": "Oxidative stress has been claimed a place in pathophysiology of depression; however, the details of the neurobiology of this condition remains incompletely understood. Recently, treatments employing antioxidants have been thoroughly researched. Ferulic acid (FA) is a phenolic compound with antioxidant and antidepressant-like effects. Herein, we investigated the involvement of the antioxidant activity of chronic oral FA treatment in its antidepressant-like effect using the tail suspension test (TST) and the forced swimming test (FST) in mice. The modulation of antioxidant system in blood, hippocampus and cerebral cortex was assessed after stress induction through TST and FST. Our results show that FA at the dose of 1 mg/kg has antidepressant-like effect without affecting locomotor activity. The stress induced by despair tests was able to decrease significantly the activities of superoxide dismutase (SOD) in the blood, catalase (CAT) in the blood and cerebral cortex and glutathione peroxidase (GSH-Px) in the cerebral cortex. Thiobarbituric acid-reactive substances (TBA-RS) levels were increased significantly in the cerebral cortex. Furthermore, the results show that FA was capable to increase SOD, CAT and GSH-Px activities and decrease TBA-RS levels in the blood, hippocampus and cerebral cortex. These findings demonstrated that FA treatment in low doses is capable to exert antidepressant-like effect with the involvement of the antioxidant defense system modulation.",
     "FAU": [
          "Lenzi, Juliana",
          "Rodrigues, Andre Felipe",
          "Ros, Adriana de Sousa",
          "de Castro, Amanda Blanski",
          "de Lima, Daniela Delwing",
          "Magro, Debora Delwing Dal",
          "Zeni, Ana Lucia Bertarello"
     ],
     "AU": [
          "Lenzi J",
          "Rodrigues AF",
          "Ros Ade S",
          "de Castro AB",
          "de Lima DD",
          "Magro DD",
          "Zeni AL"
     ],
     "AD": "Laboratorio de Analise de Substancias Bioativas, Departamento de Ciencias Naturais, Universidade Regional de Blumenau, Campus I, Blumenau, 89012-900, Santa Catarina, Brazil. Laboratorio de Fisiologia, Departamento de Ciencias Naturais, Universidade Regional de Blumenau, Blumenau, 89012900, Santa Catarina, Brazil. Laboratorio de Analise de Substancias Bioativas, Departamento de Ciencias Naturais, Universidade Regional de Blumenau, Campus I, Blumenau, 89012-900, Santa Catarina, Brazil. Laboratorio de Analise de Substancias Bioativas, Departamento de Ciencias Naturais, Universidade Regional de Blumenau, Campus I, Blumenau, 89012-900, Santa Catarina, Brazil. Laboratorio de Analise de Substancias Bioativas, Departamento de Ciencias Naturais, Universidade Regional de Blumenau, Campus I, Blumenau, 89012-900, Santa Catarina, Brazil. Departamento de Medicina, Universidade da Regiao de Joinville, Joinville, 89219-710, Santa Catarina, Brazil. Laboratorio de Fisiologia, Departamento de Ciencias Naturais, Universidade Regional de Blumenau, Blumenau, 89012900, Santa Catarina, Brazil. Laboratorio de Analise de Substancias Bioativas, Departamento de Ciencias Naturais, Universidade Regional de Blumenau, Campus I, Blumenau, 89012-900, Santa Catarina, Brazil. anazeni@furb.br.",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article",
          "Research Support, Non-U.S. Gov't"
     ],
     "DEP": "20150904",
     "PL": "United States",
     "TA": "Metab Brain Dis",
     "JT": "Metabolic brain disease",
     "JID": "8610370",
     "RN": [
          "0 (Antidepressive Agents)",
          "0 (Antidepressive Agents, Second-Generation)",
          "0 (Antioxidants)",
          "0 (Coumaric Acids)",
          "01K63SUP8D (Fluoxetine)",
          "AVM951ZWST (ferulic acid)"
     ],
     "SB": "IM",
     "EIN": [
          "Metab Brain Dis. 2015 Dec;30(6):1465. de Castro, Bianca, Blanski [Corrected to de",
          "Castro, Amanda, Blanski]. PMID: 26497810"
     ],
     "MH": [
          "Animals",
          "Antidepressive Agents/*pharmacology",
          "Antidepressive Agents, Second-Generation/pharmacology",
          "Antioxidants/*metabolism/*pharmacology",
          "Brain Chemistry/drug effects",
          "Cerebral Cortex/drug effects/metabolism",
          "Coumaric Acids/*pharmacology",
          "Fluoxetine/pharmacology",
          "Hindlimb Suspension/psychology",
          "Hippocampus/drug effects/metabolism",
          "Male",
          "Mice",
          "Motor Activity/drug effects",
          "Stress, Psychological/metabolism/psychology",
          "Swimming/psychology"
     ],
     "OTO": [
          "NOTNLM"
     ],
     "OT": [
          "Antidepressant-like effect",
          "Antioxidative/oxidative stress",
          "Ferulic acid",
          "Fluoxetine"
     ],
     "EDAT": "2015/09/06 06:00",
     "MHDA": "2016/08/24 06:00",
     "CRDT": [
          "2015/09/06 06:00"
     ],
     "PHST": [
          "2015/05/20 00:00 [received]",
          "2015/08/26 00:00 [accepted]",
          "2015/09/06 06:00 [entrez]",
          "2015/09/06 06:00 [pubmed]",
          "2016/08/24 06:00 [medline]"
     ],
     "AID": [
          "10.1007/s11011-015-9725-6 [doi]",
          "10.1007/s11011-015-9725-6 [pii]"
     ],
     "PST": "ppublish",
     "SO": "Metab Brain Dis. 2015 Dec;30(6):1453-63. doi: 10.1007/s11011-015-9725-6. Epub 2015 Sep 4.",
     "term": "hippocampus"
}